RedHill Biopharma Ltd (RDHL)

[Amatuer17]

Agree on low SP but at least you cannot say much about it as you defend the extreme low price on your other favourite stock staying at 1.16

Here the number of trials going in P2 and P3 are very large- none of them is delayed or stalled.
Company has good mgmt team, build good cash position and gives very clear updates.

All this is making company to execute all trials effectively in 2017 which they have been doing in 2016.